التفاصيل البيبلوغرافية
| العنوان: |
The Severity of Congenital Hypothyroidism With Gland-In-Situ Predicts Molecular Yield by Targeted Next-Generation Sequencing. |
| المؤلفون: |
Levaillant, Lucie, Bouhours-Nouet, Natacha, Illouz, Frédéric, Jager, Jessica Amsellem, Bachelot, Anne, Barat, Pascal, Baron, Sabine, Bensignor, Candace, De La Perriere, Aude Brac, Braik Djellas, Yasmine, Caillot, Morgane, Caldagues, Emmanuelle, Campas, Marie-Neige, Caquard, Marylène, Cartault, Audrey, Cheignon, Julie, Decrequy, Anne, Delemer, Brigitte, Dieckmann, Katherine, Donzeau, Aurélie |
| المصدر: |
Journal of Clinical Endocrinology & Metabolism; Sep2023, Vol. 108 Issue 9, pe779-e788, 10p |
| مصطلحات موضوعية: |
CONGENITAL hypothyroidism, DNA sequencing |
| مستخلص: |
Introduction: Congenital hypothyroidism with gland-in-situ (CH-GIS) is usually attributed to mutations in the genes involved in thyroid hormone production. The diagnostic yield of targeted next-generation sequencing (NGS) varied widely between studies. We hypothesized that the molecular yield of targeted NGS would depend on the severity of CH. Methods: Targeted NGS was performed in 103 CH-GIS patients from the French national screening program referred to the Reference Center for Rare Thyroid Diseases of Angers University Hospital. The custom targeted NGS panel contained 48 genes. Cases were classified as solved or probably solved depending on the known inheritance of the gene, the classification of the variants according to the American College of Medical Genetics and Genomics, the familial segregation, and published functional studies. Thyroid-stimulating hormone at CH screening and at diagnosis (TSHsc and TSHdg) and free T4 at diagnosis (FT4dg) were recorded. Results: NGS identified 95 variants in 10 genes in 73 of the 103 patients, resulting in 25 solved cases and 18 probably solved cases. They were mainly due to mutations in the TG (n = 20) and TPO (n = 15) genes. The molecular yield was, respectively, 73% and 25% if TSHsc was ≥ and < 80 mUI/L, 60% and 30% if TSHdg was ≥ and < 100 mUI/L, and 69% and 29% if FT4dg was ≤ and > 5 pmol/L. Conclusion: NGS in patients with CH-GIS in France found a molecular explanation in 42% of the cases, increasing to 70% when TSHsc was ≥ 80 mUI/L or FT4dg was ≤ 5 pmol/L. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Clinical Endocrinology & Metabolism is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
